YABAO PHARM is a generic drug manufacturer focused on Metabolic, Oncology.
YABAO PHARM's Key Drugs
YABAO PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
YABAO PHARM's Recent FDA Approvals
New NDA/BLA approvals for YABAO PHARM over the last two years — novel drugs only, excluding generics and label supplements.
YABAO PHARM's Therapeutic Areas
YABAO PHARM's approved drugs and pipeline span 2 therapeutic areas, led by Metabolic and Oncology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
YABAO PHARM's Top Competitors
YABAO PHARM's closest competitors by therapeutic-area and drug-target overlap include Merck, Baxter, and Johnson & Johnson. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
YABAO PHARM Pipeline Snapshot
YABAO PHARM has 8 active clinical programs from ClinicalTrials.gov — 0 Phase 3, 1 Phase 2 and 7 Phase 1.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Metabolic pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2006-07-19
- Latest
- 2024-11-21
- Applications
- 4